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Abstract
As members of the glycosaminoglycan (GAG) family, heparin and heparan sulfate (HS) are
responsible for mediation of a wide range of essential biological actions, most of which are
mediated by specific patterns of modifications of regions of these polysaccharides. To fully
understand the regulation of HS modification and the biological function of HS through its
interactions with protein ligands, it is essential to know the specific HS sequences present.
However, the sequencing of mixtures of HS oligosaccharides presents major challenges due to the
lability of the sulfate modifications, as well as difficulties in separating isomeric HS chains. Here,
we apply a sequential chemical derivatization strategy involving permethylation, desulfation and
trideuteroperacetylation to label original sulfation sites with stable and hydrophobic
trideuteroacetyl groups. The derivatization chemistry differentiates between all possible heparin/
HS sequences solely by glycosidic bond cleavages, without the need to generate cross-ring
cleavages. This derivatization strategy combined with LC-MS/MS analysis has been used to
separate and sequence five synthetic HS-like oligosaccharides of sizes up to dodecasaccharide, as
well as a highly-sulfated Arixtra-like heptamer. This strategy offers a unique capability for the
sequencing of microgram quantities of HS oligosaccharide mixtures by LC-MS/MS.
INTRODUCTION
Heparan sulfate (HS) and heparin are linear, highly negatively charged polysaccharides that
belong to the glycosaminoglycan family, with molecular weights ranging from 5 to
70kDa1,2. Through specific binding to a variety of proteins, HS and heparin have been
recognized as key factors for mediation of a wide range of biological actions, such as cell
growth control, cell signaling, cell adhesion and migration, inflammation, anticoagulation,
neural development and regeneration3-7. Their biological significance makes HS and heparin
important targets for drug discovery. One of the most studied heparin protein binding motifs
is the pentasaccharide responsible for binding antithrombin III and inhibiting the coagulation
cascade8, which has been formulated into an anticoagulant drug (Arixtra). Ongoing efforts
are identifying numerous other examples of protein-binding motifs in HS, which could be
potential drug candidates9,10. Most of the interactions between HS motifs and proteins are
structurally specific, requiring a specific sequence of modifications across an
oligosaccharide of moderate length. Changes to the HS biosynthesis pathway, whether by
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regulation or disease state, can alter such interactions leading to change or loss of function.
Thus, detailed information on these heparin/HS oligosaccharide sequences is required for a
better understanding of their structure-function relationship, as well as for the development
of HS/heparin-based drugs11.
The diversity of heparin/HS modification is what drives the biology, and what makes
sequencing of these polysaccharides so challenging. HS and heparin polysaccharide chains
are composed of glucosamine (GlcN) and uronic acid (UA) disaccharide repeat units with
various types of modifications including acetylation, sulfation and epimerization of the C-5
position of the UA. In the GlcN residue, the amine group can either be a free amine, and
acetylated amine, or a sulfated amine. The 6-O position of the GlcN residue can be sulfated,
and in uncommon but biologically important instances, GlcNS can be additionally sulfated
at the 3-O position. The uronic acid can be either glucuronic acid (GlcA) or iduronic acid
(IdoA) differing by the stereochemistry at the C-5 position, and the uronic acid can be
sulfated at the 2-O position2. The synthesis of these polysaccharides are not template-driven
like DNA, but rather are driven by untemplated enzymatic modification of the sugar
backbone, which is mediated by a complex and dynamic suite of modification enzymes12.
The result is a mixture of heparin/HS sequences that are both polydisperse and
heterogeneously modified, often resulting in isomeric sequences that differ widely in
biological functions.
The high degree of heterogeneity and negative charge in these polysaccharides caused by the
variety of chain lengths and diverse sulfation patterns makes their structural determination a
very challenging task. Rapid progresses in mass spectrometry (MS) instrumentation and
chromatography separation technique have led to an increasing use of these methodologies
in GAG structural studies13. Several MS techniques have been used for structural analyses
of GAGs including fast-atom bombardment (FAB)14,15, matrix-assisted laser desorption-
ionization (MALDI)16-18, and electrospray ionization (ESI)19-21. ESI is the most commonly
used ionization method for its gentle ionization giving minimum in-source fragmentation
and sulfate loss. Most methods for the detailed structural analysis of heparin/HS involves
either complete or partial depolymerization by either enzymatic or chemical means to obtain
disaccharides mixtures for compositional analysis or a range of oligosaccharide fractions
with different lengths for oligosaccharide analysis22,23. These methods always involve
separation of HS/heparin oligosaccharides for either off-line purification or on-line liquid
chromatography-tandem mass spectrometry (LC-MS/MS) analysis, using capillary
electrophoresis (CE)24 or high-performance liquid chromatography (HPLC)25 including
strong anion-exchange chromatography (SAX)26,27, size-exclusion chromatography
(SEC)21,28, hydrophilic interaction chromatography (HILIC)29,30, porous graphitized carbon
separation (PGC)31,32, and ion-pairing reversed-phase (IPRP)33,34 chromatography.
Disaccharide compositional profiling of HS/heparin derivatized disaccharides is useful and
allows for quantitative analysis by using commercially available disaccharides as standards.
For differentiation of isomeric disaccharides, collision induced dissociation (CID) MS/MS
or multi-stages tandem mass spectrometry (MSn) is used to generate diagnostic ions for
identifying disaccharides, and recent development in IPRP-HPLC or IPRP-UPLC technique
enabled separation of 12 common commercially available HS disaccharides allowing the use
of retention time for disaccharide identification20,33-35. While disaccharide composition
analysis uses relatively little sample and has short analysis times, significant sample
preparation is still required. Certain regions of heparin/HS have been shown to be resistant
to digestion down to disaccharides, biasing the composition results36. Another
compositional analysis method was developed by Zaia’s group using a HILIC LC-MS
platform for on-line separation and MS analysis of oligosaccharides with different lengths
derivatized from enzyme digestion29,30,37. Compositional information like numbers of
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hexuronic acid, N-acetylglucosamine, sulfate groups and acetyl groups can be obtained for
each observed oligosaccahride based on their accurate mass, and heparin/HS glycomics
profiles can be obtained and compared for different samples. While both composition
analysis methods are useful for studying patterns and trends in heparin/HS biology, they do
not reveal the detailed sequence information of the oligosaccharide units required for most
HS-protein interactions.
A major impediment to use tandem mass spectrometry for structural sequencing of heparin/
HS oligosaccharides is sulfate loss during fragmentation. As heparin/HS is collisionally
activated, one of the most common fragmentation pathways is loss of the sulfate
modification, resulting in a loss of sequence information regarding the original site of
sulfation. It has been demonstrated that the loss of sulfate groups can be minimized using a
combination of charge state manipulation and metal ion adduction19,38,39. However, delicate
optimization of buffer and ionization conditions is required for each oligosaccharide and on-
line separation of isomeric sequences is highly limited, narrowing the applicability of such
approach. Saad and Leary introduced a program called heparin oligosaccharide sequencing
tool (HOST) for automated sequencing using the results of tandem mass spectrometry for
disaccharides produced by enzyme digestion from the target oligosaccharides40. The use of
such method is limited in application to structurally homogeneous sample because of its
incompatibility with online LC separation. Besides the traditional CID, another tandem mass
spectrometry technique, electron detachment dissociation (EDD) has recently been applied
for GAG structural studies, with the capability of distinguishing GlcA from IdoA41. Like the
HOST sequencing method, additional purification step for oligosaccharides or samples with
very few contaminants is required in order to generate promising structural information.
While chemical derivatizations, for example, permethylation and acetylation, are not as
commonly applied for structural analysis of GAG oligosaccharides as for other
carbohydrates (such as N- and O-linked glycans), there were studies reported in 1980s using
sequential chemical derivatization for structural sequencing of heparin oligosaccharides with
fine structure by FAB MS42, and combined with chemical depolymerization for
monosaccharide analysis of heparin polysaccharides by chemical ionization MS coupled
with gas-liquid chromatography43. We modified this chemical derivatization scheme to
improve versatility and yield, and used it to successfully separate and sequence mixtures of
another class of GAGs, chondroitin sulfate, by LC-MSn 44. We present here a related
approach involving sequential permethylation, desulfation and pertrideuteroacetylation to
modify native HS oligosaccharides for on-line separation and structural analysis of mixtures
of HS oligosaccharides, preserving the information regarding the original sites of sulfation
and allowing for clear sequencing of heparin/HS sequences based solely on glycosidic bond
cleavages. By replacing the labile and strongly polar sulfate groups with much more stable
and hydrophobic trideuteroacetyl groups, the oligosaccharides can be separated well by
reverse-phase capillary HPLC and fragmented by MS/MS without losing information
regarding the sites of modification.
EXPERIMENTAL SECTION
Materials
HS disaccharide standards were purchased from Dextra (Reading, UK).
Chemoenzymatically synthesized Arixtra-like heptamer and five HS-like oligosaccharides
(two decamers, two dodecamers and one undecamer) were synthesized following the
procedures in previous publications45,46. Unless otherwise noted, all chemical reagents used
in the chemical derivatization scheme were purchased from Sigma-Aldrich Inc. (St. Louis,
MO).
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Chemical Derivatization of HS Oligosaccharides
A series of chemical derivatizations were performed to replace the labile and strongly polar
sulfate groups with much more stable and hydrophobic trideuteroacetyl groups, which
enable the HS oligosaccharides to be retained well and separated by RPLC and fragmented
by MS/MS without losing the information about the sulfation modifications. Detailed
procedures for the chemical derivatization have been described in our previous work for
structural analysis of CS oligosaccharides44. To adjust the method for HS oligosaccahride
analysis, some modifications have been made. Briefly, HS oligosaccharides were converted
to triethylamine (TEA) salts before being permethylated, in order to increase their solubility
in dimethyl sulfoxide (DMSO)47. For permethylation, the dried TEA salts (10-50 μg) were
re-suspended in 200 μL DMSO and 200 μL anhydrous suspension of sodium hydroxide in
DMSO (150 μg/μL) followed by addition of 100 μL iodomethane. After 5 min vortexing
and 10 min sonicating, the reaction was stopped by adding 2 mL water and sparged with
nitrogen to remove iodomethane, followed by desalting using a C18 Sep-Pak cartridge
(Waters Co.). The dried permethylated products were then converted to their pyridinium
salts for solvolytic desulfation by dissolving in 20μL DMSO containing 10% methanol and
incubated for 4h at 95°C to remove the sulfate groups48. The solvents were lyophilized and
the dried products were re-suspended in 175μL pyridine, 25μL D6-acetic anhydride and
incubated at 50°C overnight to label the original sites of sulfation with trideuteroacetyl
groups49 . The solvents were then removed by using a Speed-Vac concentrator, and the
samples were re-suspended in 20% acetonitrile/water at a concentration of 0.2μg/μl for later
analysis. An estimate of yield of fully derivatized product based on UV analysis of a dp4
mixture of heparan sulfate was 29.5% (data not shown).
LC-MS/MS Analysis
For structural analysis of each HS oligosaccharides, a RPLC-MS/MS method was used.
Buffer A was prepared as water with 1mM sodium acetate, and buffer B was 80%
acetonitrile, 20% water with 1mM sodium acetate. Online HPLC was performed on a
regular porous capillary C18 column (0.2×50mm, 3μm, 200 Å, Michrom Bioresources,
Aubum, CA), using a linear gradient of buffer B from 25%- 100% over 60min, with a flow
rate of 4μL/min and a 10μL injection at a sample concentration of 0.2μg/μL. Mass
spectrometry was performed on either a Thermo LTQ-FT instrument or Waters Synapt G2
Q-TOF mass spectrometer. Full MS and CID-MS/MS spectra were acquired in positive ion
mode, with spray voltage of 2-3kV and capillary temperature 250°C for LTQ-FT and 80°C
for Q-TOF. The collision energy was set between 40V and 50V.
By mixing the five synthesized HS-like oligomers together, online RPLC separation of HS
oligosaccharides using different C18 packing material was also compared. In addition to the
regular porous C18 column as we mentioned above, we also used a Halo C18 column with
core-shell packing materials (0.2×50mm, 2.6μm, 160 Å, Advanced Material Technology,
Wilmington, DE) for online separation. For the porous C18 column, a 70min gradient was
used from 40-100% buffer B with flow rate of 4μL/min. For the Halo C18 column, an
18min gradient was used from 35%-80% buffer B with flow rate of 9μL/min. A10μL
injection at a sample concentration of 0.2μg/μL for each of the five oligosaccharides was
used for analysis. Mass spectrometry setup was as same as we mentioned above.
RESULTS AND DISCUSSION
Chemical Derivatizations of HS Disaccharide Standards
As listed in Figure 1, the 12 common HS disaccharide standards contain the basic structure
ΔUA-GlcN, where the amine group can either be a free amine, acetylated amine, or a
sulfated amine. O-sulfation can occur at the 6-O position of the GlcN residue and/or the 2-O
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position of the ΔUA residue. Five HS disaccharides are selected to illustrate how all
possible modifications can be differentiated from each other after derivatization by MS and/
or MS/MS analysis. Structures of these disaccharides are presented in Figure 1, as well as
the structure for each derivatized product (with MS and MS/MS spectra of selected ones
shown in Figure S-1). Comparison of the derivatized products for ΔUA2S-GlcNAc6S and
ΔUA2S-GlcNS6S (Figure 1, I-A and I-S) illustrate the reason for the use of D6-acetic
anhydride, as the use of trideuteroacetylation allows for the differentiation between native
N-acetylation and peracetylation during the derivatization by mass only (Figure S-1A and
B). For sulfation positional isomers, there are three common sulfation sites as we mentioned,
including N-sulfation, 2-O-sulfation and 6-O-sulfation. By comparing two isomeric
dissacharides ΔUA2S-GlcNS and ΔUA2S-GlcN6S (Figure 1, disaccharides III-S and I-H),
the differentiation between N-sulfation and O-sulfation isomers can be easily achieved only
by their mass difference after derivatization(Figure S-1C and D). As it has been reported in
other literature about the permethylation of different types of amine groups50, our result also
showed that the free amine group in GlcN residue was converted to trimethyl quaternary
amine that could not be further modified, while a sulfated amine was converted to
monomethylated sulfoamine that was desulfated and trideuteroactylated afterwards. This
resulted in a diagnostic mass difference of 14Da between derivatized ΔUA2S-GlcN6S
(detected as M+) and ΔUA2S-GlcNS (detected as [M+H]+), which in their underivatized
forms are isomers.
Differentiation of 2-O-sulfation and 6-O-sulfation of the glucosamine by MS analysis is
more difficult. For this isomeric pair, ΔUA-GlcNS6S and ΔUA2S-GlcNS (Figure 1,
disaccharides II-S and III-S), the derivatized products were still isomers with exact same
mass which require MS/MS analysis for differentiation. For the derivatized ΔUA-GlcNS6S,
there was a trideuteroacetyl group on the 6-O position of the GlcNS residue and a methyl
group on the 2-O position of the ΔUA residue. On the opposite side, the derivatized
ΔUA2S-GlcNS had a methyl group on the 6-O position of the GlcNS residue and a
trideuteroacetyl group on the 2-O position of the ΔUA residue. Compared to the derivatized
ΔUA2S-GlcNS, the Y1 and Z1 ions of the derivatized ΔUA-GlcNS6S would be 31Da
heavier (the mass difference between a methyl group and a trideuteroacetyl group), and the
B1 and C1 ions would be 31Da lighter (Figure S-1E and F). One of the major benefits of our
derivatization strategy is the greatly increased stability of the trideuteroacetylations as
compared to the sulfation, with negligible trideuteroacetyl losses from the fragment ions
upon CID. This stability preserves the information of the site of original sulfation, allowing
the site of sulfation to be easily determined. The differentiation of this isomer pair is
achieved by simply comparing the glycosidic bond cleavage fragments generated from the
MS/MS, without requiring for the generation of cross-ring cleavage fragments as required
for chondroitin sulfate44.
With these initial results from the HS disaccharide analyses, we demonstrated that the
chemical derivatization strategy enable the differentiation between all common sulfation
patterns based on mass or solely on glycosidic bond cleavages, and therefore we can
accurately sequence HS oligosaccharides consisted with these repeating disaccharide units
up to any length amenable to glycosidic bond cleavage. However, no disaccharides
containing the rare, but biologically important, sulfation at the 3-O position of the GlcN are
commercially available. The derivatization products and characteristics of 3-O sulfated
GlcN are described below as studied using an Arixtra-like heptamer.
Structural Sequencing and LC Separation of Five Synthesized HS-like oligosaccharides
To evaluate the application of our method to longer HS oligosaccharides, we performed
sequential chemical derivatizations and LC-MS/MS analysis of five chemoezymatically
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synthesized HS-like oligosaccharides with known sequences (Table 1). Full derivatization
was achieved for all five oligosaccharides with byproducts caused primarily by the β–
elimination reaction between the carbon-4 and -5 of the GlcA during the permethylation,
with a smaller amount of byproducts apparently formed during the desulfation procedure. As
mentioned in our previous work on CS oligosaccharides44, these byproducts are notable for
not introducing species that would lead to the false identification of sites of sulfation; their
major effect is reducing the apparent sensitivity of the technique and result in shortened
oligomer sequences (direct infusion MS spectrum shown in Figure S-2). From the MS/MS
spectra of the parent ion [M+2Na]2+ for each oligosaccharides (with two decamers and two
dodecamers shown in Figure 2 and the undecamer shown in Figure S-3), we observed
sufficient sequential glycosidic bond cleavage fragments to enable accurate, full structural
sequencing of the modifications. Comparing the series of Y ions for NS-decamer and NS6S-
decamer (Figure 2A and B), the Y ions of the NS6S-decamer gave additional n×31Da mass
than the Y ions of the NS-decamer, where n is the number of the basic GlcN residue the Y
ion has. For example, Y2 ions with no GlcN residue shared the same m/z of 447 for each
decamer, and Y4 ions with only one GlcN residue had 31Da mass difference, and Y6 ions
with two GlcN residues had 62Da mass difference, and so on. Together with the similar
results obtained for other three longer oligosaccharides, the chemical derivatization strategy
was demonstrated to enable successful structural sequencing of HS-like oligosaccharides up
to dodecamer (the longest we attempted to sequence) with a single MS/MS experiment using
glycosidic bond cleavages only. We did notice detectable losses of MeOH and AcOH from
product ions, with these losses correlating strongly with the derivatization state at the 6O-
position of each precursor. These neutral mass losses from the glycosidic bond cleavage
products are always paired with the intact glycosidic bond cleavage product, making
assignment of the product ion straightforward. Additionally, the neutral loss product cannot
be mistaken for a different sequence, as the loss of MeOH or AcOH results in a mass not
consistent with a fully derivatized glycosidic bond cleavage of another related sequence.
MS/MS of the derivatized HS results primarily in glycosidic bond cleavages. Due to the
unique mass differences for each monosaccharide unit after derivatization, interpretation of
the MS/MS spectra is similar to interpretation of peptide MS/MS spectra. For example, we
refer to the compound analyzed in Figure 2A. Starting at the non-reducing end, if the
monosaccharide is GlcA, we should observe m/z of 1058.7 for Y9 ion; while if it is GlcA2S,
an m/z of 1043.2 should be observed. The presence of 1058.7 ion and absence of 1042.7 ion
indicate that it is a GlcA residue at the non-reducing end. Following with GlcA, the 2nd
residue could be GlcNS, GlcNAc, GlcNS6S, GlcNAc6S, GlcNS3S, GlcNAc3S,
GlcNS3S6S, GlcNAc3S6S; and the corresponding B2 ion for each possibility should give
m/z of 503.3, 500.3, 534.3, 531.3, 520.3, 517.3, 551.3 and 548.3. From the MS/MS spectra,
we only observed the 503.3 ion without clear signs for other ions, which indicate the second
residue is GlcNS. For the 3rd residue, we observed C3 ion with m/z of 739.5 but not 770.5,
indicating it is a GlcA not GlcA2S. For the 4th residue, we observed B4 ion with m/z of
969.5 but no other possibilities (966.5, 1000.5, 997.5, 986.5, 983.5, 1017.5 and 1014.5),
indicating it is a GlcNS. Sequencing for the rest of residues is very similar. The C5 ion with
m/z of 1205.5 but not 1236.5 indicates that it is a GlcA at the 5th residue. The B6 ion with
m/z of 1435.7 but no other possibilities (1432.7, 1466.7, 1463.7, 1452.7, 1449.7, 1483.7 and
1480.7) indicates that it is a GlcNS at the 6th residue. The C7 ion with m/z of 1671.9 but not
1702.9 indicates that it is a GlcA at the 7th residue. The B8 ion (doubly charged) with m/z
of 962.5 but not others (961.0, 978.0, 976.5, 971.0, 969.5, 986.5 and 985.0) indicates that it
is a GlcNS at the 8th residue. The last two residues –GlcA-AnMan at the reducing end are
fixed according to the synthesis protocol, and is proven by the presences of Y2 ion with m/z
of 447.3 for all five oligosaccharides. The absence of 478.3 for Y2 ion also confirmed that
the GlcA is not sulfated (see Figure S-4 for zoomed in views of the appropriate regions in
the MS/MS spectrum).
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Initial attempts at separation of the mixture of derivatized HS oligosaccharides was
performed on a standard C18 column, by mixing the five HS-like oligosaccharides together
for LC-MS-MS analysis. As shown in Figure 3A, with the optimized LC gradient, 4 of the 5
oligosaccharides were separated from each other, while NS-undecamer and NS-decamer
were overlapped. To seek better separation, we moved to a fused core, porous shell Halo
C18 column. As shown in Figure 3B, 5 oligosaccharides were separated, with better peak
shapes and narrower elution times. The core-shell design of the Halo column significantly
reduced the back pressure and allowed for a higher flow rate (9μL/min compare to 4μL/min
for standard C18 column) to be used under the pressure limit of 400 bar. With their own
optimized conditions for these two types of C18 column, the Halo column of the same
length and similar particle size was able to generate narrower peak widths and better peak
shapes in a shorter time scale. Therefore, for on-line separation of derivatized HS
oligosaccharides, the core-shell Halo column is preferred for its higher separation efficiency.
Structural Analysis of Synthesized Arixtra-like heptamer containing 3-O-sulfation
Compared to N-sulfation and 6-O-sulfation on GlcN residue, 3-O-sulfation is a relatively
rare modification for HS oligosaccharides that usually occurs only on N-sulfated GlcN. 3-O
sulfation is known to be essential for many HS-protein interactions, including antithrombin,
herpes simplex virus 1 glycoprotein D, and growth factor receptor and fibroblast growth
factor 7, indicating the important roles of this rare modification in diverse biological
functions51. For structural analysis of samples with 3-O sulfation present, there is one more
isomer pair to be considered for structural sequencing of HS oligosaccharides, which
involved the differentiation between 3-O-sulfated GlcNS and 6-O-sulfated GlcNS.
Unfortunately, no commercially-available 3-O sulfated disaccharide is available, and we
were unable to purify or synthesize such a disaccharide in any usable quantity. An Arixtra-
like heptamer containing a GlcNS6S3S residue (Figure 4A) was analyzed to study the
derivatization properties of 3-O sulfated GlcNS, and the 3-O-sulfated residue was found to
have a curious derivatization product resulting from our standard chemical derivatization
procedure. After performing complete derivatization for the heptamer, we observed the
derivatization product m/z of 901.48 with 14Da less than the theoretical calculated m/z for
complete derivatized heptamer (Figure S-5). This underpermethylation was consistent across
three attempts, suggesting that the unexpected underpermethylation was not due to improper
sample handling. Subsequent derivatization efforts with other heparan sulfate
oligosaccharides not containing 3-O sulfation did not exhibit underpermethylation. To
determine if the underpermethylation was site-specific, and to locate the position of
underpermethylation, we ran a MS/MS experiment on the parent ion with m/z of 901.48 and
interpreted the spectra by comparing the observed m/z value with the theoretical m/z value
for glycosidic bond cleavage fragments of the fully derivatized product (Figure 4C).
Compared to the theoretical m/z value, the reduction of 14Da started from the Y5 and B3
ions, with Y2, Y4 and B2 ions sharing the same m/z with their theoretical values. With these
results, we located the under-methylated position to the sulfated amine group on the
GlcNS6S3S residue, which contains only one possible position for methylation, the sulfated
amine. This also explained why the under-permethylated site was not further
trideuteroacetylated, because the free amine group generated after desulfation will only be
trideuteroacetylated to a mono-trideuteroacetylated amine group but not to a di-
trideuteroacetylated amine group. From the structure of the derivatized heptamer (Figure
4B), we found that the sulfated amine group only became inert when the 3-O position of the
same GlcN residue were sulfated, based on the fact that GlcNS6S could be fully methylated
while GlcNS6S3S could not. This finding is consistent with previously reported NMR
studies showing that the proton on the sulfated amine group of a 3-O sulfated GlcNS is
deactivated, exhibiting a much slower exchange rate compared to the amine proton on
GlcNS with no 3-O sulfation52. With these data, as illustrated in Figure 5, we conclude that
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the derivatized 3-O-sulfated and 6-O-sulfated isomers should be differentiated solely by
their 14Da mass difference from the underpermethylation of the 3-O sulfated GlcNS.
CONCLUSIONS
In this work, we have demonstrated that the sequential chemical derivatization strategy
enabled differentiation between all sulfation patterns possible based solely on glycosidic
bond cleavages from single-stage MS/MS. Therefore, we can accurately sequence all
sulfation and acetylation modifications of oligosaccharides up to any length amenable to
glycosidic bond cleavage. We have successfully sequenced synthetic HS oligosaccharides
up to dodecamers with a single MS/MS experiment solely using glycosidic bond cleavages,
which is the longest oligomer we have attempted to sequence so far. In addition, by
replacing the labile and strongly polar sulfate groups with much more stable and
hydrophobic trideuteroacetyl groups, the oligosaccharides can be retained well and separated
by reverse-phase capillary HPLC, allowing for analysis of mixtures of HS oligosaccharides
by automated online LC-MS/MS. The fused core, porous shell Halo C18 columns have been
demonstrated to give better separation than traditional C18 columns using the same gradient
but at higher flow rates.
At present, the chemical derivatization protocol combined with LC-MS/MS analysis clearly
enables the separation and sequencing of HS oligosaccharides in microgram quantities, but
further improvements are possible. One of the limitations is the sample loss and beta-
elimination byproducts generated during the permethylation, which requires homogeneous
length for oligosaccharides being analyzed. One strategy that is currently being pursued by
our group to reduce sample loss is the reduction of the carboxylic acid of the uronic acid
residues to alcohols to eliminate the beta-elimination during the permethylation step.
Additionally, our current technology does not purport to identify C-5 epimerization of the
uronic acid. Preliminary chemometric analysis results suggest that epimerization of the C-5
position of uronic acid may be differentiated by our derivatization and LC-MS/MS protocol,
but a broader sample set of analytes is required to ensure robustness of the chemometric
analysis.
In applications where a complex mixture of depolymerized heparin/HS is to be analyzed,
our methodology provides great promise, even with the issues presented by beta-elimination
byproducts unresolved. The beta-elimination byproducts do not shift the sequences of
modifications in the byproduct; the remaining sequence is a real sequence that existed in the
original mixture, merely truncated from its original size. This truncated sequence can still
provide valuable information regarding changes in the sequence. If accurate analysis of full
length is required (e.g. affinity purification analyses), then all fragments smaller than the dp
fraction size isolated from the size exclusion column can be safely ignored, leaving only
full-length sequence data if the researcher so desires.
One notable advantage to our LC-MS/MS protocol is the fact that baseline LC resolution of
isomers is not required to address mixtures of isomeric sequences. Partial separation of
isomeric sequences by as little as one MS scan in the LC-MS/MS run can successfully
identify both sequences by plotting the selection product ion chromatogram specific to each
isomeric sequence, which is possible given that our derivatization strategy only relies upon
the more abundant glycosidic bond fragments to differentiate between all isomers. While the
separation of non-isomeric HS-like oligosaccharides has been achieved in regular HPLC
system, and we have previously achieved resolution of isomeric chemically-derived GAG
sequences of chondroitin sulfate, the improved resolution granted by a nano-UPLC system
would be useful for separations of isomeric oligosaccharides mixtures where much higher
resolution is required.
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In summary, we have successfully developed and demonstrated a strategy for chemical
derivatization combined with standard reverse phase LC-MS/MS analysis using CID
fragmentation that enables the structural sequencing for heparin/HS oligosaccharides with
different modification patterns. We have used this strategy to analyze samples with as little
as 5 μg of total starting material for simple mixtures. This strategy shows tremendous
promise for sequencing of mixtures of heparin/HS oligosaccharides obtained from complex
biological systems or partial purification strategies, when detailed information about
sulfation and acetylation modifications is needed for mixtures of oligosaccharides with
certain biological activity or consequence. We anticipate that this methodology will provide
a practical strategy for sequencing of the “heparanome” from heparin/HS oligosaccharide
mixtures from various systems of biological interest, and represents a valuable follow-up to
compositional analysis studies.
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Structures of 12 commercially available common HS disaccharides before and after the
chemical derivatizations, with each corresponding molecular weight labeled. In the
structures, the symbol Me, Ac and Ac’ represents for methyl group, acetyl group and
trideuteroacetyl group respectively. GlcN, GlcNAc and GlcNS represents for free
glucosamine, acetylated glucosamine and N-sulfated glucosamine respectively. 2S and 6S
indicate the position of the sulfate group. ΔUA represents for unsaturated uronic acid.
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MS/MS spectra from the LTQ analyzer of an LTQ-FT of [M+2Na]2+ for NS-decamer (A),
NS6S-decamer (B), NS-dodecamer (C) and NS6S-dodecamer (D) after the chemical
derivatizations. Sufficient sequential glycosidic bond cleavage fragments were observed for
each synthesized HS-like oligosaccharides, which enable the accurate and complete
structural sequencing.
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LC separation of derivatized products of five synthesized HS-like oligosaccharides by
reverse-phase C18 column packed with either traditional porous material (A) or fused core-
porous shell material (B). Same colors in two chromatograms represent the same
oligasaccharide as indicated on the right side. For porous C18 column (50mm, 200Å, 3μm):
4 of the 5 oligosaccharides were separated, with NS-hendecamer and NS-decamer co-eluted
at 45.29min. For core-shell Halo C18 column (50mm, ~160Å, ~2.6μm): 5 oligosaccharides
were able to be separated from each other or at least partially separated.
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Structures of the synthesized Arixtra-like heptamer before (A) and after (B) the
derivatizations. Two black arrows indicated the different behavior during the derivatization
between GlcNS6S and GlcNS6S3S residues, which was interpreted from the MS/MS spectra
and the comparison between theoretical and observed m/z values for each glycosidic bond
cleavage fragment as obtained from a Synapt G2 HDMS Q-TOF (C).
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Prediction for the structure of the derivatized product of 3-O-sulfated HS disaccharide
ΔUA-GlcNS3S, and there is a 14Da mass difference between 3-O-sulfated and 6-O-sulfated
isomeric disaccharides after derivatizations.
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